HORIZONFP7H2020
Universite de Kinshasa
- Country
- CDCongo - Kinshasa
- Defence projects
- 0
- Projects, all programmes
- 12
- As coordinator
- 0
- EU contribution (CORDIS)
- EUR 8,016,526
- Active
- 2008 to 2025
Projects
12 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| AFRICAI-RIA Pan-African Research Infrastructure for Collaborative Biomedical Imaging and Artificial Intelligence in Respiratory Care | HORIZON | 2025 | Participant | Not stated |
| PregInPoxVacMATERNAL AND INFANT SAFETY AND IMMUNOGENICITY IN A PHASE 3, OPEN-LABEL, RANDOMISED, VACCINE TRIAL OF A TWO-DOSE MPOX VACCINE | HORIZON | 2024 | Participant | EUR 754,078 |
| MPOX-PROBEStrengthening epidemiological, genomic and community surveillance of Mpox virus (MPXV) at the Congo River border for DRC and RoC | HORIZON | 2024 | Participant | EUR 329,306 |
| SAFIRESAFETY OF ANTIMALARIALS IN THE FIRST TRIMESTER: AN ADAPTIVE PLATFORM TRIAL | HORIZON | 2024 | Participant | EUR 67,437 |
| CATCRCentral Africa Training Platform for Clinical Research on infectious diseases | HORIZON | 2024 | Participant | EUR 905,144 |
| PYRAPREG-extendedEfficacy and Safety of a newly registered Artemisinin-Based Combination (Pyronaridine-Artesunate -PYRAMAX®) for the treatment of uncomplicated malaria in African pregnant women - Extended | HORIZON | 2024 | Participant | EUR 250,000 |
| ODIN-MPoxImplementing wastewater and environmental surveillance for Mpox in Sub-Saharan Africa | HORIZON | 2024 | Participant | EUR 332,500 |
| SEMA ReACTSEvere MAlaria treatment with Rectal artesunate and Artemisinin-based Combination Therapy [in remote settings] | HORIZON | 2023 | Participant | EUR 1,120,581 |
| ODINStrengthening Environmental Surveillance to Advance Public Health Action | HORIZON | 2023 | Participant | EUR 540,500 |
| VERDISARS-coV2 variants Evaluation in pRegnancy and paeDIatrics cohorts | HORIZON | 2021 | Participant | EUR 297,829 |
| EBOVAC3Bringing a prophylactic Ebola vaccine to licensure | H2020 | 2018 | Participant | EUR 3,293,131 |
| MAFEMigration between Africa and Europe | FP7 | 2008 | Participant | EUR 126,020 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.